Glucagon-like peptide-1 (GLP-1, 7-36) is capable of restoring normal glucose tolerance in aging, glucose-intolerant Wistar rats and is a potent causal factor in differentiation of human islet duodenal homeobox-1-expressing cells into insulin-releasing  cells. Here we report stable isotope-based dynamic metabolic profiles of rat pancreatic epithelial (ARIP) and human ductal tumor (PANC-1) cells responding to 10 nM GLP-1 treatment in 48 h cultures. Macromolecule synthesis patterns and substrate flow measurements using gas chromatography/mass spectrometry (MS) and the stable [1,2-13 C 2 ]glucose isotope as the tracer showed that GLP-1 induced a significant 20% and 60% increase in de novo fatty acid palmitate synthesis in ARIP and PANC-1 cells, respectively, and it also induced a significant increase in palmitate chain elongation into stearate utilizing glucose as the primary substrate. Distribution of 13 C in other metabolites indicated no changes in the rates of nucleic acid ribose synthesis, glutamate oxidation, or lactate production. Tandem Glucagon-like peptide-1 (GLP-1; 7-36) of the intestine enhances insulin secretion from pancreatic  cells in response to food intake and restores normal glucose tolerance in glucose-intolerant aging Wistar rats (1). Expression of insulin mRNA and high insulin contents were described after transfection of insulinoma cells with the GLP-1 receptor in epithelial cells of the pancreas (2). Additionally, both rat and human cells readily differentiate into insulin-secreting cells in response to GLP-1 treatment (3, 4). Cell differentiation and insulin release by pancreatic cells in response to GLP-1 require the presence of functioning specific receptors and the presence of the islet duodenal homeobox-1 (PDX-1) transcript protein, which translocates to the nucleus (5). This process is triggered by a ligand-induced activation of adenylyl cyclase that increases intracellular cAMP levels, which, in turn, activate protein kinase A during epithelial cell differentiation (6, 7).Stable isotope-based dynamic metabolic profiling (SID-MAP) technology helps detail mechanisms of hormone actions by revealing genotype-phenotype-metabolome interactions and by tracking metabolic pathway substrate flow changes ( Fig. 1 ) (8, 9). Fatty acid metabolism appears to be a critical factor in cell differentiation and in mediating the antitumor activities of newly characterized potent kinase targeting treatment modalities (10-13). In the present study, we have investigated the metabolic substrate flow regulating effects of GLP-1 in two epithelial tumor cell lines, which both differentiate into insulin-secreting  -like cells in culture. This paper demonstrates that cell differentiation and regulation of insulin release after GLP-1 treatment are accompanied by important metabolic adaptive changes that primarily affect the contribution of glucose to de novo fatty acid synthesis and chain elongation of the saturated long-chain species primarily utilized for triglyceride and membrane synthesis.
MATERIAL...